We are proud to support a World-first trial for paediatric brain cancer
A world-first clinical trial, known as The Deflexifol® At Relapse Trial (DART), proudly supported […]
$1 million donation allows Genetic Predisposition Testing for Childhood Cancer at Westmead
In March 2023, we committed $1 million to Sydney Children’s Hospitals Foundation to fund […]
